Last Updated: 07/24/2014 00:43:28
SECCY Stock Chart - 1 Month
SECCY Stock Chart - 3 Month
SECCY Stock Chart - 6 Month
SECCY Stock Chart - 1 Year
SECCY Stock Chart - 2 Year
Grappling with the Tucson Heat: AC Dilemmas You're smack in the middle of a blistering Tucson summer, and guess what? Your AC decides to take a dive. Happens, right? The HelloNation article, drawing on insights from HVAC expert Dan Barrios, gives the skinny on whether you should repair or replace that grumpy old unit. Understanding the Age Factor in AC Systems Here's the...
Continue Reading
H.I.G. Capital Completes Acquisition of GetixHealth H.I.G. Capital, a premier global alternative investment firm with a substantial portfolio valued at $68 billion, has recently announced a compelling strategic investment in GetixHealth, LLC. This collaboration marks a significant step forward in enhancing the offerings of GetixHealth in the realm of healthcare revenue...
Continue Reading
Financial Highlights from LivePerson’s Third Quarter 2025 LivePerson, Inc. (NASDAQ: LPSN), a prominent leader in conversational AI and digital transformation, has released its financial results for the third quarter of 2025. The company achieved remarkable total revenue of $60.2 million, exceeding expectations and demonstrating its resilience in meeting customer...
Continue Reading
The Future of Regional Aviation: Introducing the D328eco As regional airlines in the U.S. navigate the challenges of rising operational costs and workforce shortages, the need for fleet renewal becomes increasingly critical. The aviation sector faces this urgency head-on, particularly with the aging fleet of 30 to 50-seat aircraft. With significant demand for improved...
Continue Reading
Vincerx Pharma Announces Strategic Merger with Oqory, Inc. Vincerx Pharma, Inc. (NASDAQ: VINC), a pioneering biopharmaceutical company dedicated to meeting the challenges faced by cancer patients, has made a bold move by entering into a strategic merger with Oqory, Inc. This partnership is filled with potential, as Oqory specializes in developing antibody-drug conjugates...
Continue Reading